Rasamanikya: Benefits, Evidence & Safety

TL;DR

Rasamanikya is a classical Ayurvedic mineral medicine made by heat-processing Hartala (orpiment, arsenic trisulphide), traditionally used for chronic skin disorders, cough and breathing difficulty. A 2026 review found animal studies showed no toxicity up to 2000 mg/kg and clinical reports used 125–250 mg twice daily, but no large human trials exist. Because it contains arsenic, use only under qualified supervision.

(60 words. Sources: JAIMS 2026 review; NCCIH Ayurvedic Medicine: In Depth.)

Heavy-metal warning: Rasamanikya deliberately contains arsenic as arsenic trisulphide (As₂S₃). Arsenic is a known toxicant, and Ayurvedic metal-containing products have repeatedly tested above safety limits. This formulation must only be used under the supervision of a qualified practitioner, from a tested, reputable source: never self-prescribed.

What it is

Rasamanikya (also spelled Rasmanikya) is a classical mineral formulation of Rasa Shastra, the Ayurvedic discipline of herbo-mineral pharmacy. It is prepared from Shuddha Hartala, purified orpiment, chemically arsenic trisulphide (As₂S₃), heated between sheets of mica (abhraka patra) until the mass turns a coppery red. The name refers to this ruby-like colour, not to any ruby content (classical Ayurvedic reference aggregator, Tier 3). A 2026 peer-reviewed review traces its textual basis to the Rasa Tarangini, Rasendra Chintamani, Rasendra Sara Sangraha and Siddhabheshaja Manimala, and reports that pharmaceutical processing of Hartala into Rasamanikya reduces crystallinity and particle size with minor oxidation (Chauhan et al., J Ayurveda Integr Med Sci 2026).

Two caveats: the review notes that raw Hartala is "known to be toxic due to the presence of free arsenic," and composition varies across manufacturers, some commercial variants add further minerals and herbs, so no single ingredient list represents every product on the market (JAIMS 2026).

Traditional use

Classical and traditional sources describe Rasamanikya as balancing aggravated Vata and Kapha, with traditional indications including chronic skin disorders (kushtha) such as eczema, boils and leucoderma, vatarakta (gout-like joint disorders), jwara (fever), kasa (cough) and shwasa (breathing difficulty/asthma) (classical Ayurvedic reference aggregator, Tier 3; JAIMS 2026). These are traditional indications recorded in Rasa Shastra literature: they are not proof that the formulation works.

What modern research says

Animal toxicity studies

The 2026 JAIMS review pooled acute and sub-acute toxicological assessments in animal models and reported no mortality or severe adverse effects at doses up to 2000 mg/kg (Chauhan et al., JAIMS 2026) (animal toxicity studies). This is a high-dose animal finding, not evidence of safety in humans, in pregnancy, or with long-term use.

Small clinical reports

The same review cites small clinical reports, including an open-label trial in Vicharchika (atopic dermatitis) and studies in eczema and Amavata (rheumatoid arthritis), and reports that therapeutic doses of 125–250 mg twice daily with adjuvants were well tolerated in those reports (JAIMS 2026) (small clinical reports, mostly open-label). The review's authors conclude that clinical evidence supports efficacy in chronic dermatological, respiratory and immune-related disorders, but these are preliminary reports, not large randomized trials: and no large RCT of Rasamanikya was identified.

Laboratory pharmacodynamics

The review summarizes laboratory literature attributing anti-inflammatory, immunomodulatory, antioxidant and antiproliferative properties to processed arsenic trisulphide (JAIMS 2026) (laboratory studies). These describe the chemistry of the compound, not proven clinical effects of the medicine.

Bottom line: the modern evidence base is thin: animal toxicity data, laboratory characterization, and small open-label clinical reports. There are no large human trials establishing either efficacy or long-term safety.

Safety & contraindications

This formulation contains arsenic and requires the strongest cautions:

FAQs

What is Rasamanikya made of?

Classically, it is made from a single mineral: purified Hartala (orpiment, arsenic trisulphide, As₂S₃), heated between mica sheets until it turns coppery red. Its ruby-like colour gives it the name. Some commercial variants add other minerals and herbs, so the exact composition varies by manufacturer (JAIMS 2026).

What is it traditionally used for?

Traditional Rasa Shastra sources indicate it for chronic skin disorders (eczema, boils, leucoderma), gout-like joint complaints, fever, cough and breathing difficulty, framed as balancing aggravated Vata and Kapha. These are classical indications, not clinically proven effects (classical aggregator, Tier 3).

Is there scientific evidence that it works?

Very little. A 2026 peer-reviewed review found animal toxicity studies (no severe effects up to 2000 mg/kg), laboratory characterization, and small open-label clinical reports in skin disorders and arthritis. No large randomized trial of Rasamanikya exists, so efficacy is unproven (JAIMS 2026).

What dose is used?

Small published clinical reports used 125–250 mg twice daily with adjuvants. That describes what researchers tried: it is not a recommendation for general use. Because the formulation contains arsenic, dosing must come only from a qualified practitioner (JAIMS 2026).

Why is the arsenic content a concern?

Arsenic is a known toxicant, and the medicine is deliberately manufactured from an arsenic compound. NCCIH warns that some Ayurvedic preparations contain toxic amounts of lead, mercury or arsenic, and notes that Ayurvedic products have, in rare cases, caused arsenic poisoning (NCCIH).

Can it be taken during pregnancy or given to children?

No. There are no safety data for pregnancy, breastfeeding or children, and arsenic exposure carries particular risk in these groups. Avoid use; any consideration of it must involve a qualified clinician (NCCIH).

Sources

Tier 1 (Ayush/CCRAS, pharmacopoeial, peer-reviewed journals):

Tier 2 (NHS/NCCIH — safety):

Tier 3 (classical aggregators, labeled as such):

Disclaimer

This article is for educational purposes only and is not medical advice. Consult a qualified practitioner before using any Ayurvedic formulation. Rasamanikya contains arsenic and must never be used without prescription and supervision by a qualified practitioner experienced in rasa medicines — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.